FDA Adverse Event
Injury
Summary report: N
ENDOTAK RELIANCE
MDR report key: 2163063
·
Received July 15, 2011
Report
- Report Number
- 2124215-2011-07370
- Event Type
- Injury
- Date Received
- July 15, 2011
- Date of Event
- April 21, 2011
- Report Date
- April 27, 2011
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVY
- PMA / PMN Number
- P910073
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
Additional Manufacturer Narrative · 1
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
Additional Manufacturer Narrative · 1
TO DATE, THERE HAVE BEEN NO ADVERSE PATIENT EFFECTS REPORTED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PRODUCT WAS PART OF A SYSTEM EXPLANT DUE TO THE PRODUCTS ERODING THROUGH THE PATIENT'S SKIN. THERE WAS NO REPORT OF ADVERSE PATIENT EFFECTS DUE TO THE EXPLANT PROCEDURE.
Description of Event or Problem · 1
SUBSEQUENT INFORMATION RECEIVED INDICATED A NEW SYSTEM WAS IMPLANTED ON THE RIGHT SIDE. DEFIBRILLATION THRESHOLD (DFT) TESTING WAS UNSUCCESSFUL DUE TO THE PATIENT'S HIGH DFTS. A LIFE VEST PLANNED TO BE PLACED ON THE PATIENT FOR ONE MONTH UNTIL ANOTHER SYSTEM COULD BE IMPLANTED ON THE LEFT SIDE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDOTAK RELIANCE | IMPLANTABLE LEAD | NVY | CPI - DEL CARIBE | 0158 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 79 YR | Life Threatening| R | 4470| A135| 0158| T165 |